MARKET

TECH

TECH

Bio-Techne Corp
NASDAQ
77.31
+0.94
+1.23%
Closed 16:16 07/12 EDT
OPEN
76.73
PREV CLOSE
76.37
HIGH
78.47
LOW
76.15
VOLUME
1.32M
TURNOVER
0
52 WEEK HIGH
89.91
52 WEEK LOW
51.61
MARKET CAP
12.18B
P/E (TTM)
61.48
1D
5D
1M
3M
1Y
5Y
1D
Bio-Techne's (NASDAQ:TECH) 8.6% CAGR outpaced the company's earnings growth over the same five-year period
Bio-Techne Corporation's share price is down 6.6% in the last year. The company has grown its earnings per share at 9.9% a year over the last five years. The share price of the company is up 48% in five years, but less than the market return. Over the longer term, the company's fundamentals are better than the share price.
Simply Wall St · 7h ago
Weekly Report: what happened at TECH last week (0708-0712)?
Weekly Report · 8h ago
These are the stocks with the highest increase in short interest within life sciences and diagnostics - Baird
Exact Sciences Corp. Had the highest percentage increase in shares sold short within the life sciences and diagnostics sector at the end of June vs. The prior month. Five stocks within the sector saw more than 10% increase in short interest through May. Twist Bioscience had the lowest percentage of short interest in the sector.
Seeking Alpha · 2d ago
GMAB or TECH: Which Is the Better Value Stock Right Now?
NASDAQ · 6d ago
Weekly Report: what happened at TECH last week (0701-0705)?
Weekly Report · 07/08 09:15
Weekly Report: what happened at TECH last week (0624-0628)?
Weekly Report · 07/01 09:15
Should Weakness in Bio-Techne Corporation's (NASDAQ:TECH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Simply Wall St · 06/27 10:45
RBC Capital Reaffirms Their Hold Rating on Bio-Techne (TECH)
TipRanks · 06/25 01:45
More
About TECH
Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

Webull offers BIO-TECHNE Corp stock information, including NASDAQ: TECH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TECH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TECH stock methods without spending real money on the virtual paper trading platform.